These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25791180)

  • 1. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
    van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
    Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
    Huhtaniska S; Jääskeläinen E; Heikka T; Moilanen JS; Lehtiniemi H; Tohka J; Manjón JV; Coupé P; Björnholm L; Koponen H; Veijola J; Isohanni M; Kiviniemi V; Murray GK; Miettunen J
    Psychiatry Res Neuroimaging; 2017 Aug; 266():73-82. PubMed ID: 28618327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between brain morphology and outcome in schizophrenia in a general population sample.
    Jääskeläinen E; Juola P; Kurtti J; Haapea M; Kyllönen M; Miettunen J; Tanskanen P; Murray GK; Huhtaniska S; Barnes A; Veijola J; Isohanni M
    Eur Psychiatry; 2014 Sep; 29(7):456-62. PubMed ID: 24342739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
    Nesvåg R; Frigessi A; Jönsson EG; Agartz I
    Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies.
    Vita A; De Peri L; Deste G; Barlati S; Sacchetti E
    Biol Psychiatry; 2015 Sep; 78(6):403-12. PubMed ID: 25802081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.
    Guo JY; Huhtaniska S; Miettunen J; Jääskeläinen E; Kiviniemi V; Nikkinen J; Moilanen J; Haapea M; Mäki P; Jones PB; Veijola J; Isohanni M; Murray GK
    Schizophr Res; 2015 Oct; 168(1-2):297-304. PubMed ID: 26189075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic and benzodiazepine use and brain morphology in schizophrenia and affective psychoses - Systematic reviews and birth cohort study.
    Huhtaniska S; Korkala I; Heikka T; Björnholm L; Lehtiniemi H; Hulkko AP; Moilanen J; Tohka J; Manjón J; Coupé P; Kiviniemi V; Isohanni M; Koponen H; Murray GK; Miettunen J; Jääskeläinen E
    Psychiatry Res Neuroimaging; 2018 Nov; 281():43-52. PubMed ID: 30219591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.
    Stip E; Mancini-Marïe A; Letourneau G; Fahim C; Mensour B; Crivello F; Dollfus S
    Int Clin Psychopharmacol; 2009 Jan; 24(1):34-41. PubMed ID: 19077676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
    Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
    Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.
    Quarantelli M; Palladino O; Prinster A; Schiavone V; Carotenuto B; Brunetti A; Marsili A; Casiello M; Muscettola G; Salvatore M; de Bartolomeis A
    Biomed Res Int; 2014; 2014():325052. PubMed ID: 25157354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the effects of antipsychotic drugs on brain volume.
    Moncrieff J; Leo J
    Psychol Med; 2010 Sep; 40(9):1409-22. PubMed ID: 20085668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
    Yue Y; Kong L; Wang J; Li C; Tan L; Su H; Xu Y
    PLoS One; 2016; 11(1):e0147204. PubMed ID: 26789520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.
    Cahn W; Hulshoff Pol HE; Lems EB; van Haren NE; Schnack HG; van der Linden JA; Schothorst PF; van Engeland H; Kahn RS
    Arch Gen Psychiatry; 2002 Nov; 59(11):1002-10. PubMed ID: 12418933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.
    Veijola J; Guo JY; Moilanen JS; Jääskeläinen E; Miettunen J; Kyllönen M; Haapea M; Huhtaniska S; Alaräisänen A; Mäki P; Kiviniemi V; Nikkinen J; Starck T; Remes JJ; Tanskanen P; Tervonen O; Wink AM; Kehagia A; Suckling J; Kobayashi H; Barnett JH; Barnes A; Koponen HJ; Jones PB; Isohanni M; Murray GK
    PLoS One; 2014; 9(7):e101689. PubMed ID: 25036617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.